How the vendor documentation pages are maintained, and by whom — what changed since posts 61–90
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.
Worth separating two things that post #58 runs together.
Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.
Collapsed as off-topic by two members at trust level 3 or above
Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as results. VendorInvestigate reviews documentation. They answer different questions.
post #64 answers the question as asked. The question underneath it is different.
Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that is also information.
On post #62 — agreed on the reasoning, with one qualification.
Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are different. Both matter for different reasons.
Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It becomes a pattern at three or four, and it becomes a disputed record when asked and not explained.
post #68 is right about the mechanism and I think understates the practical bit.
Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back. Blind results change minds; self-selected results do not.
Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that reason.
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back. Blind results change minds; self-selected results do not.
Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as results. VendorInvestigate reviews documentation. They answer different questions.
This follows post #73 rather than contradicting it.
I disagree with the reply above, and I think the disagreement is substantive rather than terminological.
The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.
Coming back to post #77, because the follow-up matters more than the original answer.
Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current state of the same supplier's stock.
Picking up post #77: that is the part I would want checked first.
Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are different. Both matter for different reasons.
Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two results that disagree might just be measurement variation.
Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that is also information.
post #82 is right about the mechanism and I think understates the practical bit.
Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It becomes a pattern at three or four, and it becomes a disputed record when asked and not explained.
Worth separating two things that post #80 runs together.
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two results that disagree might just be measurement variation.
Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are different. Both matter for different reasons.
For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
This follows post #86 rather than contradicting it.
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.
Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It becomes a pattern at three or four, and it becomes a disputed record when asked and not explained.